Launch of HIV medication, Lenacapavir to be held on Friday President Cyril Ramaphosa is expected to launch the roll out of the lifesaving HIV prevention injectable medicine, Lenacapavir, later this ...
The first shipment of Lenacapavir, a long-acting injectable that prevents HIV with two shots a year, arrived in South Africa ...
HIV treatment has been improved and simplified significantly over the years, yet a small fraction of people living with HIV ...
Health experts say false claims about the lenacapavir injection could undermine efforts to reduce new HIV infections in South ...
Lenacapavir, which protects people from H.I.V. infection with twice-yearly shots, is arriving in a country where the health ...
South Africa partners with Unitaid to produce generic lenacapavir by 2026. Discover how this HIV breakthrough improves access and health sovereignty. Read more.
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced a strategic partnership agreement with the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) ...
South Africans living with HIV will soon have a new treatment option available to them in the form of Lenacapavir, or Yeztugo as it is also referred to by its creator, Gilead Sciences. The drug, which ...
LAGOS Nigerians living with HIV who achieve virological suppression can expect to live for 33 years without transmitting the virus, according to health experts, as nationwide training begins for the ...